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ABSTRACT 
Particles with sizes in the order of a few micrometers can significantly enhance the capabilities of optoacoustic imaging 
systems by improving visualization of arbitrarily oriented vascular structures and achieving resolution beyond the 
acoustic diffraction barrier. Particle tracking may also be used for mapping the blood flow in two and three dimensions. 
However, a trade-off exists between the particle absorption properties and size, whereas large sized microparticles also 
tend to arrest in the capillary network. We analyzed the flow of microparticles in an intracardiac perfusion mouse model 
in which blood is effectively substituted by artificial cerebrospinal fluid (ACSF). This enables mitigating the strong 
blood absorption background in the optoacoustic images thus facilitating the visualization of microparticles. A sequence 
of three-dimensional optoacoustic images of the mouse brain is then acquired at a high frame rate of 100 Hz after 
injection of the particles in the left heart ventricle. By visualizing the flow of particles of different sizes in microvascular 








The endogenous contrast provided by blood empowers optoacoustic (OA, photoacoustic) tomography (OAT) with 
unique capabilities for angiographic imaging [1,2]. Blood pool contrast agents can enhance the contrast at the expense of 
a higher optical attenuation and lower achievable depth, hence are generally not used for rendering images of vascular 
structures at multiple spatial scales [3,4,5,6]. The onset of OAT systems with real-time imaging capabilities in two- and 
three dimensions have facilitated mapping the flow of blood pool agents, which resulted in a new capability to define 
perfusion-related bio-markers [7,8,9]. However, most contrast enhancement approaches used in OAT are based on active 
or passive targeting agents [10]. In this regard, absorbing dyes and nanoparticles smaller than 200 m are generally used, 
which cannot be individually detected in the presence of a large concentration of highly absorbing red blood cells 
(RBCs). 
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Being able to detect individual particles can significantly enhance the OAT imaging performance. For example, the 
fluctuations induced by flowing particles have been used to enhance the visibility under limited-view conditions and the 
imaging resolution in phantom experiments [11,12]. Fluctuations associated to the flow of RBCs have also been 
observed with transducers operating at higher frequencies, which have also been exploited for image enhancement 
[12,13]. Localization of individual particles further enabled forming images with a resolution significantly beyond the 
acoustic diffraction barrier [14,15,16], which can massively boost the OAT imaging performance. The applicability of 
these approaches in vivo relies however on the availability of sufficiently absorbing microparticles that do not cause 
damage to the animal e.g. by blocking the capillary network. 
 
Herein, we make use of an intracardiac perfusion mouse model that effectively substitutes blood by artificial 
cerebrospinal fluid (ACSF) to visualize the flow of microparticles in the mouse brain. The aim is to extract some 




2.1 Intracardiac perfusion model 
 
The intracardiac perfusion model has been recently described [17]. First, the mouse was anesthetized via intraperitoneal 
injection of 87.5 mg/kg Ketamine (Bremer Pharma, Wabing, Germany) and 12.5 mg/kg Xylazine (Bela-pharm, Vechta, 
Germany). 75 U of Heparin (Ratiofarm GbmH, Ulm, Germany) diluted in 100 ml 0.9% NaCl Solution (Braun AG, 
Melsungen, Germany) was additionally injected intraperitonially. A lethal dose of 87.5 mg/kg Ketamine (Bremer 
Pharma, Wabing, Germany) and 12.5 mg/kg Xylazine (Bela-pharm, Vechta, Germany) was then injected after placing 
the mouse in supine position and fixing it with a custom-made stereotactic holder (Narishige International Limited, 
London, UK) and needles in its extremities (Fig. 1a). The ventral portion of the rib cage was removed with an incision 
from the mid abdomen to the sternum and ACSF was supplied with Carbogen (Linde Group, Munich, Germany) through 
a 25G butterfly needle inserted in the left ventricle. The right atrium was opened with an incision to guarantee perfusion 
of ACSF and removal of blood. The ACSF pressure was maintained below the physiological maximum of 100 mmHg 
throughout the measurements. All the animal experiments were carried out in accordance with the regulations of the 
Helmholtz Center Munich and with approval from the Government District of Upper Bavaria. 
 
2.2 Optoacoustic tomographic imaging system 
 
OAT imaging of the mouse brain was performed with a previously described spherical array (Imasonic SaS, Voray, 
France) consisting of 512 piezocomposite elements densely distributed on a spherical surface with 40 mm radius and 
140° angular coverage [18]. The individual elements of the array have 5 MHz central detection frequency and >80% -
6dB bandwidth. An optical parametric oscillator (OPO)-based laser (Innolas GmbH, Krailling, Germany) tuned to 
700 nm optical wavelength and 100 Hz pulse repetition frequency was used to illuminate the sample via a custom-made 
fiber bundle (Ceramoptec GmbH, Bonn, Germany) inserted in an 8 mm central aperture of the array. The volume 
enclosed between the mouse head and the detection surface of the array was filled with agar. The light fluence at the 
surface of the mouse was maintained below 20 mJ/cm2. Images were reconstructed with a graphics processing unit 
(GPU) implementation of a back-projection formula [19]. 
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Microparticles were intracardially injected in the mouse through the butterfly needle inserted in the left ventricle. 
Specifically, absorbing polyethylene microspheres with diameter ranges of 20-27 m (Cospheric BKPMS 20-27um) and 
10-20 m (Cospheric BKPMS 10-20um) were suspended in phosphate buffered saline (PBS) with 3% Tween 20 
surfactant. Approximately 1 ml of each suspension was injected. All the animal experiments were carried out in 




Figure 1: Intracardiac perfusion model. (a) Lay-out of the experimental set-up. ACSF – artificial cerebrospinal fluid, HC 
– heating coil, PT – pressure transducer, OPO – optical parametric oscillator laser, PC – personal computer, DAQ – data 
acquisition system, FB – fiber bundle, LB – light beam, SA – spherical array. (b) Three dimensional views of the 




Fig. 1b shows three-dimensional views of the OAT images of the mouse brain for 3 different instants during ACSF 
perfusion. It is shown that most of the blood is effectively removed from the brain. This facilitates imaging of small 
particles which would otherwise be arguably shadowed by the strong background absorption. Fig. 2 displays the 
maximum intensity projections (MIPs) along the depth direction of the OAT images for 4 different time points during the 
injection of 10-20 m (top) and 20-27 m particles (bottom). It is shown that the 20-27 m particles could clearly be 
detected as they flow before being permanently arrested in the capillary network. On the other hand, the 10-20 m could 
also be detected, although the signal intensity is lower. This is expected considering that the strength of the OA signal 
generated by a particle is in principle proportional to the total energy being absorbed in the volume of the particle. These 
smaller particles also arrested in the capillary network. However, the amount of observed particles in the image 
decreased with time after injection. This could indicate slower flow for some of the particles. 
 
2.3 Microparticle injection 
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Figure 2: Visualization of microparticle flow. Maximum intensity projections (MIPs) along the x, y and z directions of 





The results presented in this work illustrate the feasibility to visualize and track microparticles in the mouse vascular 
network. Capillary arrest was however observed due to the large particle size. This effect was lower for the smallest 
microparticles, which as expected generated OA signals with less amplitude. Overall, it was shown that solid particles 
larger than 10 m do not efficiently flow within vascular structures, so that smaller particles are required for the in vivo 
applicability of localization optoacoustic tomography (LOT) and other super-resolution methods based on image 
fluctuations induced by particle flow. 
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